Status:
SUSPENDED
Playful Sensorimotor Training in Pediatric Brain Tumor Patients
Lead Sponsor:
University of Basel
Collaborating Sponsors:
Kantonsspital Aarau
Conditions:
Pediatric Cancer
Pediatric Brain Tumor
Eligibility:
All Genders
6-18 years
Phase:
NA
Brief Summary
Chemotherapy-induced peripheral neuropathy (CIPN) is a highly prevalent and clinically relevant side-effect of cancer treatment. The severe symptoms such as loss of sensation, numbness, pain, absent r...
Eligibility Criteria
Inclusion
- patients with a central nervous system (CNS) tumor
- age: ≥ 6 and ≤ 18 years
- neurotoxic chemotherapy treatment is completed 3 months to 2 years ago
- neurotoxic chemotherapy comprised a platinum-derivate or vinca-alkaloid (low grade gliomas: vincristine/carboplatin or vinblastin mono and embryonal tumors as well as ependymomas: cisplatin/ lomustine and vincristine or cyclophosphamide/ carboplatin/ vincristine/ etoposide)
Exclusion
- neuropathies of other cause (e.g. diabetes)
- disabilities
- lack of German language that prevent the understanding of the informed consent as well as the instructions for training
Key Trial Info
Start Date :
May 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03334162
Start Date
May 1 2019
End Date
November 1 2020
Last Update
April 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kantonspital Aarau
Basel, Switzerland, 4056